Patents by Inventor B. Naidu

B. Naidu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

HIV integrase inhibitors

Publication number: 20070111984

Abstract: The invention encompasses a series bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.

Type: Application

Filed: October 31, 2006

Publication date: May 17, 2007

Inventors: B. Naidu, Yasutsugu Ueda, John Matiskella, Michael Walker, Jacques Banville, Francis Beaulieu, Carl Ouellet, Serge Plamondon
HIV integrase inhibitors

Publication number: 20070111985

Abstract: The invention encompasses a series bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.

Type: Application

Filed: November 10, 2006

Publication date: May 17, 2007

Inventors: B. Naidu, Margaret Sorenson, Yasutsugu Ueda, John Matiskella, Michael Walker
Bicyclic heterocycles as HIV integrase inhibitors

Publication number: 20060276466

Abstract: The invention encompasses a series cyclic bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.

Type: Application

Filed: August 16, 2006

Publication date: December 7, 2006

Inventors: B. Naidu, Jacques Banville, Francis Beaulieu, Timothy Connolly, Mark Krystal, John Matiskella, Carl Ouellet, Serge Plamondon, Roger Remillard, Margaret Sorenson, Yasutsugu Ueda, Michael Walker
Bicyclic heterocycles as HIV integrase inhibitors

Publication number: 20060199956

Abstract: The invention encompasses a series cyclic bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.

Type: Application

Filed: November 29, 2005

Publication date: September 7, 2006

Inventors: B. Naidu, Jacques Banville, Francis Beaulieu, Timothy Connolly, Mark Krystal, John Matiskella, Carl Ouellet, Serge Plamondon, Roger Remillard, Margaret Sorenson, Yasutsugu Ueda, Michael Walker
HIV integrase inhibitors: cyclic pyrimidinone compounds

Publication number: 20060106007

Abstract: The invention encompasses a series of pyrimidinone compounds which inhibit HIV integrase and thereby prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses intermediates useful for making the pyrimidone compounds. Additionally, pharmaceutical compositions and methods for treating those infected with HIV are encompassed.

Type: Application

Filed: November 14, 2005

Publication date: May 18, 2006

Inventors: B. Naidu, Timothy Connolly, Yasutsugu Ueda
Bicyclic heterocycles as HIV integrase inhibitors

Publication number: 20050267132

Abstract: The invention encompasses a series cyclic bicyclic heterocyclic compounds of Formula I which are inhibitors of HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.

Type: Application

Filed: May 26, 2005

Publication date: December 1, 2005

Inventors: Jacques Banville, Gilles Bouthillier, B. Naidu, Roger Remillard, Michael Walker
Bicyclic heterocycles as HIV integrase inhibitors

Publication number: 20050267131

Abstract: The invention encompasses a series cyclic bicyclic heterocyclic compounds of Formula I which are inhibitors of HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.

Type: Application

Filed: May 26, 2005

Publication date: December 1, 2005

Inventors: B. Naidu, Jacques Banville, John Matiskella, Serge Plamondon, Yasutsugu Ueda
Bicyclic heterocycles as HIV integrase inhibitors

Publication number: 20050267105

Abstract: The invention encompasses a series cyclic bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.

Type: Application

Filed: May 11, 2005

Publication date: December 1, 2005

Inventors: B. Naidu, Jacques Banville, Francis Beaulieu, Timothy Connolly, Mark Krystal, John Matiskella, Carl Ouellet, Serge Plamondon, Roger Remillard, Margaret Sorenson, Yasutsugu Ueda, Michael Walker
HIV integrase inhibitors

Publication number: 20050261322

Abstract: Compounds of the present disclosure are spirocycle-substituted pyrimidinecarboxamides. Also disclosed are pharmaceutical compositions comprising the compounds, and methods of using the compounds. The compounds are useful for treating HIV infection and AIDS.

Type: Application

Filed: May 12, 2005

Publication date: November 24, 2005

Inventors: B. Naidu, Margaret Sorenson
HIV integrase inhibitors: cyclic pyrimidinone compounds

Publication number: 20050256109

Abstract: The invention encompasses a series of pyrimidinone compounds which inhibit HIV integrase and thereby prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses intermediates useful for making the pyrimidone compounds. Additionally, pharmaceutical compositions and methods for treating those infected with HIV are encompassed.

Type: Application

Filed: April 20, 2005

Publication date: November 17, 2005

Inventor: B. Naidu